Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
PaperCitations, authors & open-access status
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 384 citations, 2016 year and bronze oa status.
384
Citations
2016
Year
bronze
OA Status